Best Growth Hormone Peptides 2026: CJC-1295, Ipamorelin & Tesamorelin Compared

A comprehensive ranking of every GH secretagogue — who should use which, and why

Source: https://indexalabs.com/blog/best-growth-hormone-peptides-2026-compared Abstract: The growth hormone peptide landscape has matured significantly. With multiple GHRH analogues, GHRPs, and combination products available, choosing the right protocol depends on your research goals. This guide compares CJC-1295 No DAC, Ipamorelin, Tesamorelin, and their combinations across efficacy, side effects, cost, and suitability for different objectives.

Understanding GH Peptide Classes: GHRH vs GHRP

Before comparing individual peptides, it’s essential to understand the two fundamental classes:

GHRH Analogues (Growth Hormone-Releasing Hormone): These mimic the hypothalamus’s natural signal to the pituitary, telling it to produce and release GH. They work WITH the body’s existing rhythm. Examples: CJC-1295 No DAC (Mod GRF 1-29), CJC-1295 with DAC, Sermorelin, Tesamorelin.

GHRPs (Growth Hormone-Releasing Peptides): These work through the ghrelin/GHS receptor to amplify GH release AND suppress somatostatin (the GH brake). They can trigger GH release even when GHRH signalling is low. Examples: Ipamorelin, GHRP-6, GHRP-2, Hexarelin.

The Key Distinction: GHRH analogues are like pressing the accelerator — they only work when conditions allow. GHRPs are like pressing the accelerator AND releasing the handbrake simultaneously. This is why combining one from each class produces synergistic results.

Oral Secretagogues: MK-677 (Ibutamoren) deserves mention as an oral ghrelin mimetic that provides 24-hour GH elevation. While not a peptide (it’s a non-peptide small molecule), it’s frequently discussed alongside GH peptides.

Head-to-Head Comparison Table

Feature	CJC-1295 No DAC	Ipamorelin	Tesamorelin
Class	GHRH analogue	GHRP (ghrelin mimetic)	GHRH analogue
Half-life	~30 minutes	~2 hours	~26 minutes
GH pulse type	Sharp, pulsatile	Clean, moderate	Sharp, pulsatile
Best for	Stacking with GHRP	General GH optimisation	Visceral fat reduction
Cortisol impact	None	None	None
Prolactin impact	None	None	None
Hunger stimulation	None	None	None
Desensitisation risk	Low	Very low	Low
FDA-studied	No	No	Yes (lipodystrophy)
Standalone efficacy	Moderate	Good	Good
Best used with	Any GHRP	CJC-1295 No DAC	Standalone or with GHRP
Difficulty level	Intermediate	Beginner	Beginner–Intermediate

Notable absence: GHRP-6 and GHRP-2 are intentionally excluded from this ranking. While effective, their side effects (intense hunger, cortisol elevation, prolactin increase) make them inferior choices for most research applications. Hexarelin is excluded due to rapid desensitisation.

Detailed Peptide Profiles

CJC-1295 No DAC (Mod GRF 1-29)

• Mechanism: Synthetic GHRH analogue with four amino acid substitutions for improved stability
• Strength: Produces the most physiological GH pulse pattern when combined with a GHRP
• Weakness: Limited standalone efficacy — needs a GHRP partner for optimal results
• Best for: Researchers who want the gold standard stack (pair with Ipamorelin)
• Dosage: 100 mcg per injection, 2–3 times daily

Ipamorelin

• Mechanism: Selective ghrelin receptor agonist — triggers GH release without affecting cortisol, prolactin, or appetite
• Strength: Cleanest side effect profile of any GHRP; minimal desensitisation; suitable for extended use
• Weakness: GH elevation is moderate compared to more aggressive GHRPs
• Best for: Beginners, long-term anti-aging protocols, female researchers, anyone prioritising safety
• Dosage: 100–300 mcg per injection, 2–3 times daily

Tesamorelin

• Mechanism: Synthetic 44-amino-acid GHRH analogue — the only GH peptide with FDA-recognised clinical data for visceral fat reduction
• Strength: Targeted visceral fat mobilisation; robust clinical evidence; well-studied safety profile
• Weakness: Requires higher doses (1–2 mg daily); more expensive per protocol
• Best for: Visceral fat reduction, metabolic health, researchers who want the strongest evidence base
• Dosage: 1–2 mg daily, single injection

Which Peptide Is Right for Your Research Goals?

Goal: General Anti-Aging & Wellness → Ipamorelin alone or CJC-1295 + Ipamorelin stack

• Rationale: Clean, sustainable GH optimisation with minimal intervention. The stack provides stronger results; Ipamorelin alone is suitable for those wanting simplicity.

Goal: Body Recomposition (Fat Loss + Muscle) → CJC-1295 + Ipamorelin stack

• Rationale: The synergistic GH pulse drives both lipolysis and protein synthesis. Add a post-workout dose for maximum anabolic benefit.

Goal: Targeted Belly Fat / Visceral Fat → Tesamorelin (standalone or + Ipamorelin)

• Rationale: Tesamorelin has the strongest clinical evidence specifically for visceral adiposity. Adding Ipamorelin enhances the overall GH response.

Goal: Injury Recovery → CJC-1295 + Ipamorelin + BPC-157

• Rationale: Systemic GH elevation supports tissue repair while BPC-157 provides targeted healing. This triple stack is the most popular recovery protocol.

Goal: Maximum GH Output → CJC-1295 + Ipamorelin + MK-677 (oral)

• Rationale: MK-677 provides baseline 24-hour GH elevation; the injectable stack adds pulsatile peaks. Monitor blood glucose. Advanced researchers only.

Goal: Simplicity / First-Time User → Ipamorelin alone

• Rationale: One peptide, one reconstitution, clean side effect profile, effective standalone. Graduate to the full stack after establishing response.

Cost and Practical Considerations

Monthly Cost Comparison (approximate, at standard doses):

• Ipamorelin alone (200 mcg 2x/day): 1 vial per month — most affordable option
• CJC-1295 + Ipamorelin (100 mcg + 200 mcg 2x/day): 1 vial each per month — moderate cost
• Tesamorelin (2 mg/day): 2–3 vials per month — highest per-protocol cost
• Tesamorelin + Ipamorelin: Highest combined cost but most targeted fat loss

Practical Factors:

• Injection frequency: All protocols require subcutaneous injection 1–3 times daily. If needle frequency is a concern, Ipamorelin once daily pre-bed still delivers meaningful benefits.
• Storage: All peptides require refrigeration after reconstitution and should be used within 28 days
• Travel: Lyophilised (unreconstituted) vials are stable at room temperature for weeks, making travel manageable
• Stacking convenience: CJC-1295 and Ipamorelin can be combined in the same syringe, so the stack doesn’t double injection burden

Quality Matters: GH peptides are only as effective as their purity. Look for third-party HPLC and mass spectrometry testing with verified purity ≥98%. Low-purity peptides produce inconsistent GH responses and may contain degradation products.